Adcock Ingram has turned its focus to bulking up the production capacity of its facility in Wadeville to counter the effect that port congestion has had on the availability of its over-the-counter (OTC) brands.

The R8.8bn JSE-listed pharmaceutical company on Wednesday said delays at SA’s ports limited product and raw material availability in the six months to end-December. ..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.